Sj. Wimalawansa et al., MECHANISMS OF THE ANTIHYPERTENSIVE EFFECTS OF DIETARY CALCIUM AND ROLE OF CALCITONIN-GENE-RELATED PEPTIDE IN HYPERTENSION, Canadian journal of physiology and pharmacology, 73(7), 1995, pp. 981-985
Alterations in calcium metabolism and calcium-regulating hormones have
been described in essential hypertension. However, the mechanisms tha
t mediate these responses are unknown. In previous studies, using the
genetically spontaneously hypertensive rat and the mineralocorticoid-s
alt (DOG-salt) hypertensive rat model, we and others have observed tha
t oral calcium supplementation attenuates the associated increase in p
eripheral vascular resistance and consequently lowers blood pressure (
BP). When hypertensive patients (n = 8, diastolic BP 90-95 mmHg (1 mmH
g = 133.3 Pa)) were given daily oral calcium supplementation (1.4 g el
emental calcium), both systolic and diastolic BP were decreased (5-10
mmHg, p < 0.01). The only biochemical variables significantly changed
were serum ionized calcium and intact parathyroid hormone (PTH, 1-84)
(p < 0.05); furthermore, the levels of calcitonin gene related peptide
(CGRP), measured by both radioimmunoassay and radioreceptor assay, sh
owed a marked 75% increase (p < 0.001). The antihypertensive effects o
f Ca2+ and the increased levels of CGRP in the circulation returned to
baseline levels immediately following cessation of calcium supplement
ation, suggesting that the effects of calcium on BP and CGRP are speci
fic. On the basis of these observations we propose that the antihypert
ensive effect of dietary calcium supplementation, at least in part, is
mediated through CGRP.